U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
161491161491Automatic Control of Pressure Support Ventilation in Surgical Intensive Care UnitsCompletedNo Results AvailableVentilator WeaningDevice: SmartCare/PShttps://ClinicalTrials.gov/show/NCT00445289
161492161492Symptomatic Efficacy of Diacerein in Knee OsteoarthritisCompletedNo Results AvailableKnee OsteoarthritisDrug: Diacereinhttps://ClinicalTrials.gov/show/NCT00445276
161493161493Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST ElevationTerminatedHas ResultsCORONARY DISEASEDrug: TIROFIBAN|Procedure: CORONAROGRAPHYhttps://ClinicalTrials.gov/show/NCT00445263
161494161494The Role of Calcipotriol as Radioprotector of SkinNot yet recruitingNo Results AvailableRadiodermatitisDrug: Calcipotriolhttps://ClinicalTrials.gov/show/NCT00445250
161495161495Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major DepressionCompletedNo Results AvailableMajor DepressionDevice: H1 and H2 deep TMS coilshttps://ClinicalTrials.gov/show/NCT00445237
161496161496Comparing Rehabilitation Programs for Patellofemoral Pain SyndromeCompletedHas ResultsPatellofemoral Pain SyndromeOther: Hip Progressive Resistive Exercise|Other: Quad Progressive Resistive Exerciseshttps://ClinicalTrials.gov/show/NCT00445224
161497161497HEROIC (Heparin Requirement in Counterpulsation)CompletedNo Results AvailableCardiogenic ShockDrug: Heparinhttps://ClinicalTrials.gov/show/NCT00445211
161498161498A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological MalignanciesCompletedNo Results AvailableSmall Cell Lung Cancer|Small Cell Lung CarcinomaDrug: ABT-263https://ClinicalTrials.gov/show/NCT00445198
161499161499Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrixâ„¢CompletedNo Results AvailableHepatitis BBiological: Henogen HB vaccine|Biological: Fendrix vaccinehttps://ClinicalTrials.gov/show/NCT00445185
161500161500A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)Active, not recruitingNo Results AvailableAmyotrophic Lateral Sclerosis (ALS)Drug: E0302 (mecobalamin)https://ClinicalTrials.gov/show/NCT00445172
161501161501UT-15C SR in the Treatment of Critical Limb IschemiaRecruitingNo Results AvailableCritical Limb IschemiaDrug: UT-15C SR (treprostinil diethanolamine) 1mg oral tabletshttps://ClinicalTrials.gov/show/NCT00445159
161502161502Safety of Ritonavir-Boosted Elvitegravir Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 InfectionCompletedNo Results AvailableHIV InfectionsDrug: Elvitegravir|Drug: Ritonavir|Drug: ARV regimenhttps://ClinicalTrials.gov/show/NCT00445146
161503161503Study on Magnetic Field Therapy to Improve Quality of Sleep and Reduction of Chronic Spine PainRecruitingNo Results AvailableBack Pain|Neck Pain|Sleep Initiation and Maintenance DisordersDevice: Magnetic Sleep Padhttps://ClinicalTrials.gov/show/NCT00445133
161504161504Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis TreatmentCompletedNo Results AvailableVernal KeratoconjunctivitisDrug: Lactobacillus Rhamnosus GG|Drug: placebo (sugar)https://ClinicalTrials.gov/show/NCT00445120
161505161505SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)CompletedNo Results AvailableAsthmaDrug: MK0476, montelukast sodium / Duration of Treatment: 8 Weekshttps://ClinicalTrials.gov/show/NCT00445107
161506161506A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)(COMPLETED)CompletedNo Results AvailableInfection|PneumoniaDrug: MK0787B, imipenem/cilastatin sodium / Duration of Treatment: 7 Days|Drug: Comparator: amikacin / Duration of Treatment: 3 Days|Drug: Comparator: tazocin / Duration of Treatment: 3 Days|Drug: Comparator: vancomycin / Duration of Treatment: 3 Dayshttps://ClinicalTrials.gov/show/NCT00445094
161507161507Prednisolone vs. Ciclosporine in Severe Atopic EczemaCompletedNo Results AvailableAtopic DermatitisDrug: Prednisolone|Drug: Ciclosporine Ahttps://ClinicalTrials.gov/show/NCT00445081
161508161508Efficacy and Safety of LBH589B in Adult Patients With Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaDrug: LBH589https://ClinicalTrials.gov/show/NCT00445068
161509161509Evaluation of 2 Doses of Intravenous Droperidol in the Prevention of Postoperative NauseaTerminatedNo Results AvailableNausea|VomitingDrug: Droperidolhttps://ClinicalTrials.gov/show/NCT00445055
161510161510Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerCompletedNo Results AvailableCarcinoma, Renal CellDrug: Sorafenibhttps://ClinicalTrials.gov/show/NCT00445042
161511161511Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin InflammationRecruitingNo Results AvailableAllergic Contact Dermatitishttps://ClinicalTrials.gov/show/NCT00445029
161512161512Neurologic Complications in Peripheral Regional Anesthesia - An Evaluation Based on a Standardized ProtocolActive, not recruitingNo Results AvailableAnesthesia, Conduction|Nerve Block|Adverse EffectsProcedure: peripheral regional anesthesiahttps://ClinicalTrials.gov/show/NCT00445016
161513161513Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyCompletedHas ResultsProliferative Diabetic Retinopathy|Diabetic Macular EdemaDrug: Ranibizumab|Drug: Triamcinolone Acetonide|Behavioral: Sham injection|Procedure: Focal/grid laserhttps://ClinicalTrials.gov/show/NCT00445003
161514161514Study on Magnetic Field Therapy to Improve Chronic Lumbar PainRecruitingNo Results AvailableLow Back PainDevice: Magnetic Flex Padhttps://ClinicalTrials.gov/show/NCT00444990
161515161515Enhancing Oral Health Care Use by HIV Positive IndividualsCompletedNo Results AvailableOral Health Care|HIV Infections|Mouth DiseasesBehavioral: Case-management linkage interventionhttps://ClinicalTrials.gov/show/NCT00444977
161516161516Growth Hormone Use in Adults With Prader-Willi SyndromeRecruitingNo Results AvailablePrader-Willi SyndromeDrug: Nutropin AQhttps://ClinicalTrials.gov/show/NCT00444964
161517161517Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi ArabiaCompletedHas ResultsNeisseria Meningitidis|Meningococcal InfectionsBiological: Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine|Biological: Mencevax®: Group A, C, W135 and Y polysaccharide meningococcal vaccine|Biological: Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccinehttps://ClinicalTrials.gov/show/NCT00444951
161518161518Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device in the Treatment of Bipolar DepressionCompletedNo Results AvailableBipolar DepressionDevice: H1 -coil TMS devicehttps://ClinicalTrials.gov/show/NCT00444938
161519161519Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)CompletedHas ResultsOveractive BladderDrug: fesoterodine fumarate|Drug: placebo|Drug: tolterodine tartratehttps://ClinicalTrials.gov/show/NCT00444925
161520161520The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)CompletedHas ResultsNon-Hodgkin Lymphoma|Hodgkin DiseaseDrug: G-CSF plus plerixafor|Drug: G-CSF plus plerixafor|Biological: rituximabhttps://ClinicalTrials.gov/show/NCT00444912

* Görseller ve İçerik tekif hakkına sahip olabilir